Meditation as primary intervention strategy in prevention of cardiovascular diseases

Authors

  • Yadneshwar Khobragade Department of Community Medicine, Melaka-Manipal Medical College (MMMC), Melaka
  • Adinegara Bin Lutfi Abas Department of Community Medicine, Melaka-Manipal Medical College (MMMC), Melaka
  • Barua Ankur Department of Public Health Medicine, International Medical University, Kuala Lumpur
  • Sujata khobragade Department of Community Medicine, Melaka-Manipal Medical College (MMMC), Melaka

DOI:

https://doi.org/10.18203/2320-6012.ijrms20160003

Keywords:

Meditation, Healthy lifestyle, Hypertension, Coronary artery disease, Myocardial infarction, Equanimeous, Non-judgemental, Mindfulness, Hostility, Stress, Anxiety

Abstract

Heart diseases especially Hypertension, Coronary Artery Diseases (CAD) and stroke are the leading causes of death all over the world. Hostility, anxiety, depression and increased reactivity to mental stress have been strongly associated with hypertension and CAD. Mental stress or anxiety causes increased sympathetic activation and poor vagus nerve control over heart.  Imbalance between sympathetic and parasympathetic nervous system leads to vasospasm and has been associated with Hypertension, Coronary Artery Disease and Myocardial Infarction. Psychosocial stress has also been found to be responsible for imbalance in autonomic nervous system, causing sympathetic dominance over parasympathetic leading to acute coronary events. Meditation is a process of self-contemplation and purification of mind. Practitioner of meditation brings about desirable changes in their behaviour and lifestyle. During Meditation sympathetic activity is reduced and there is parasympathetic dominance over sympathetic. During meditation and after meditation person feels calm, quiet and relaxed. Meditation causes decrease in metabolic rate. The blood pressure may come to normal or falls, pulse rate comes to normal or low, vascular spasm if any, is reduced and myocardial perfusion increase. Thus meditation helps in preventing hypertension, coronary artery disease and other cardiac events.  This may be beneficial before a person gets coronary event and post-myocardial infarction.   In view of the beneficial effects of meditation, it may be introduced as primary intervention strategy in preventing Cardio-vascular Diseases. We did this review study to find out: (1) Can meditation bring about desirable changes in human mind and body in post-intervention group compared to control group? (2) Its effectiveness in prevention of heart diseases like hypertension, coronary events and post-MI complications. This review included all randomised controlled trials on patients above 18 years, both sexes, any setting with medication & meditation or meditation, Controlled group was on medication alone. Clustered and crossover studies were excluded.

References

Lay UK. Manual of Vipassana Meditation. 3rd Ed. Igatpuri, India: Vipassana Research Institute. 2008. ISBN 978-81-7474-220-0.

Emani S, Binkley PF. Mind body medicine in chronic heart failure: A transnational science challenge. Circ Heart failure. 2010;3:715-25

Allison TG, Williams DE, Miller TD, Patten CA, Bailey KR, Squires RW et al. Medical and economic costs of psychological distress in patients with coronary artery disease. Mayo clinic procedures. 1995;70(8):734-42.

Shapiro PA. Psychiatric Aspects of Cardiovascular Disease. Psychiatric Clinics of North America. 1996;19(3):613-29.

Sgoutas-Emch SA, Cacioppo JT, Uchino BN, Malarkey W, Pearl D, Kiecolt-Glaser JK et al. The effects of an acute psychological stress or on cardiovascular, endocrine, and cellular immune response: A prospective study of individuals high and low in heart rate reactivity. Psychophysiology. 1994;31(3):264-71.

Johansson G, Laakso ML, Karonen SL, Peder A. Examination Stress affects plasma levels of TSH and Thyroid Hormones Differently in Females and Males. Psychosomatic Medicine .1987;49(4):390-6.

Esler M. The autonomic Nervous System and Cardiac Arrhythmias. Clinical Autonomic Research. 1992;2(2):133-5.

Ziegelstein RC. Acute Emotional Stress & Cardiac Arrhythmia. JAMA. 2007;298(3):324-9.

Harrisons Principle of Internal Medicine. 17 editions. Vol. 2. US: McGraw-Hill Professional. 2008:1375-9.

Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular Disease. Geneva: The World Health Organization. 2002.

Wig NN. World Health Day, Indian Journal of Psychiatry. 2001;43(1):1-4.

Schwartz BG, Mayeda GS, Burstein S, Economides C, Kloner RA. When and why do heart attacks occur? Cardiovascular Triggers and their Potential Role. Hosp Pract Minneap. 2010;38(5):144-52.

Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-7.

Simula S, Vanninen E, Viitanen L, Kareinen A, Lehto S, Pajunen P et al. Cardiac Adrenergic Innervation is affected in Asymptomatic Subjects with Very Early Stage of Coronary Artery Disease. Journal of Nuclear Medicine.2002;43(1):1-7.

Maura Paul-Labrador, MPH; Donna Polk, MD, MPH; James H. Dwyer, PhD†; Ivan Velasquez, MD; Sanford Nidich, PhD; Maxwell Rainforth, PhD; Robert Schneider, MD; C. Noel Bairey Mer. Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease Arch Intern Med. 2006;166(11):1218-24.

Curiati JA, Bocchi E, Freire JO, Arantes AC, Braga M, Garcia Y et al. Meditation reduces sympathetic activation and improves quality of life in elderly patients with optimally treated heart failure: A prospective randomised study. J Alt and Compl Med. 2005;11(3);465-72.

Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in Stable Angina. Circulation. 1990;81(3):748-56.

Benson H, Malhotra MS, Goldman RF, Jacobs GD, Hopkins PJ. Three case reports of the metabolic and electroencephalographic changes during advanced Buddhist meditation techniques. Behavioural Medicine. 1990;16:90-5.

Newton AB, Iversen J. The neural basis of the complex mental task of meditation. Neurotransmitter and Neurochemical considerations. Med Hypotheses. 2003;61(2):283-91.

Jevning R, Wallace RK, Beidebach M. The physology of meditation: A review. A wakeful hypometabolic integrated response. Neurosci Biobehav Rev. 1992;16:415-24.

Wallace RK, Benson H. A wakeful hypometabolic physiologic state. American Journal of Physiology. 1971;221:795-9.

William H. Art of living: Vipassana Meditation: As taught by S.N. Goenka. New York: Harper Collins Publishers.1987.

Korkushko OV, Frolkis MV, Yaroshenko YT. Hormonal Supply during Physical Exercise in elderly patients with IHD. Gerontology. 1988; 34(1-2):88-94.

MacLean CR, Walton KG, Wenneberg SR, Levitsky DK, Mandarino JP, Waziri R et al. Effect of TM programme on adaptive mechanisms: Changes in hormonal levels and responses to stress after four months practice. Psycho-neuroendocrinology. 1997;22(4):277-95.

Brzezinski A. Mechanisms of disease: melatonin in humans. New England Journal of Medicine. 1997;336:186-95.

Herrmann JM. Essential hypertension and stress: When do yoga, psychotherapy and autogenic training help? MMW Fortschr Med. 2002;144(19):38-41.

Porges SW. Cardiac vagus tone: a physiological index of stress. Neurosciences and Behavioural Review. 1995;19(2):225-3.

David S, Ludwig JKZ. Clinical mindfulness and Patient safety. JAMA. 2010;304(22);2532-3.

Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium-dependent and independent vascular responses in the coronary microcirculation. Circulation. 1995;92(3):518-25.

White VD. Relaxation Therapy for rehabilitation and prevention in Ischemic heart disease: a systematic review and meta-analysis. Euro J cardiovasc prev Rehabili. 2005;12(3):193-202.

Linden W, Stossel C, Maurice J. Psychosocial Interventions for patients with coronary artery disease: A meta-analysis. Arch Intern Med. 1996;156(7):745-52.

Zamerra JW, Schneider RH, Besseghini I, Robinson DK, Salerno JW. Usefulness of Transcendental Meditation Programme in the treatment of coronary artery disease. Am J Cardiology. 1996;77(10):867-70.

Sudsuang R. Effect of buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiology and Behavior. 1991;50(3):543-8.

Gupta SK, Sawhney RC, Rai L, Chavan VD, Dani S, Arora RC et al. Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients- Mount Abu Open heart Trial. Indian Heart J. 2011;63(5):461-9.

Manar M, Nabolsi RN, Alexander M, Carson RN. Spirituality, illness and personal responsibility: the experience of Jordanian Muslim men with coronary artery disease. Scandinavian Journal of Caring Sciences. 2011:25(4):716-24.

Doufesh H, Ibrahim F, Ismail N. Assessment of heart rate and blood pressure in different SalatPositions. J Phys the Sci. 2013;25(2):211-4.

Blackwell B, Bloomfield S, Gartside P, Robinson A, Hanenson I, Magenheim H et al. Transcendental meditation in hypertension. 1976;307(7953):223-6.

Mathers CD, Lopez A, Stein C, Fat MD, Rao C, M. Inoue, and others. 2001. "Deaths and Disease Burden by Cause: Global Burden of Disease Estimates for 2001 by World Bank Country Groups." In Disease Control Priorities Project Working Paper 18. Bethesda,

The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: WHO. 2002b.

Ahsan A, Khan M, Siddhique R. The Healing Power of prayer in Islam. Indian J Positive Psychology. 2012;3(2):168-72.

Goshvarpour A, Goshvarpour A. Recurrence Plots of Heart Rate Signals during Meditation. I J Image, Graphics and Signal Processing. 2012;4(2):44-50.

Liu CY, Wei CC, Lo PC. Variation Analysis of Sphygmogram to Assess Cardiovascular System under Meditation. Evid Based Complement Alternat Med. 2009;6(1):107-12.

Sheps DS, Sheffield D. Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. J Clin Psychiatry. 2001;62( Suppl 8):12-6.

Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI, King CG et al. Stress Reduction in the Secondary Prevention of Cardiovascular Disease. Circulation: Cardiovascular Quality and Outcomes. 2012;5:750-8.

Walton KG, Pugh ND, Gelderloos P, Macrae P. Stress reduction and preventing hypertension: Preliminary support for a psych neuroendocrine mechanism; Journal of Alternative & Complementary Medicine. 1995;1(3):263-83.

Seer P, Raaeburn JM. Meditation Training and essential hypertension: A methodological study; Journal of Behavioral Medicine. Journal of Behavioral Medicine. 1980;3:59-71.

Blumenthal James A, Babyak Michael A, Ironson Gail, Thorensen Carl, Powell Lynda, Czajkowski Susan, Berg matthew et al. Spirituality, Religion and Clinical outcomes in patients recovering from Acute Myocardial Infarction; Psychosomatic Medicine. 2007;69(6):501-8.

Keyworth C, Knopp J, Roughley K, Dickens C, Bold S, Coventry P. A Mixed-Methods Pilot Study of the Acceptability and Effectiveness of a Brief Meditation and Mindfulness Intervention for People with Diabetes and Coronary Heart Disease. Behav Med. 2014;40(2):53-64.

Anna MT, Jacalyn M, Yvonne C, Patrick R. Mindfulness Meditation, Anxiety Reduction, and Heart Disease: A Pilot Study; Family & Community Health. Fam Community Health. 2003;26(1):25-33

Warber SL, Ingerman S, Moura V, Wunder J. Healing the heart: a randomized pilot study of a spiritual retreat for depression in acute coronary syndrome patients. Explore The Journal of Science and Healing. 2011;7(4):222-33.

Downloads

Published

2016-12-24

How to Cite

Khobragade, Y., Abas, A. B. L., Ankur, B., & khobragade, S. (2016). Meditation as primary intervention strategy in prevention of cardiovascular diseases. International Journal of Research in Medical Sciences, 4(1), 12–21. https://doi.org/10.18203/2320-6012.ijrms20160003

Issue

Section

Review Articles